Chinese PE Firm Shiyu Capital Leads $131M Series A Round In Biotech Start-Up

Login to View

Lepu Biotech, a Chinese biotechnology firm specialized in tumor immunotherapy, has raised RMB900 million (US$131.47 million) in a series A round of financing led by the country’s healthcare-focused private equity firm Shiyu Capital, according to a statement released on Monday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in